Outsourcing Pharma

JANUARY 9, 2024

Pharma company Mercaptor has announced its new âbreakthroughâ technology at J.P. Morgan HealthCare Conference which it says could transform Alzheimer's, TBI, and epilepsy treatment.

Pharma Companies 89

Pharma Companies Clinical Development Development 89

pharmaphorum

APRIL 19, 2021

The UK’s unique offering as a life sciences research hub helped convince US biotech Novavax to develop its COVID-19 jab there, according to the head of the country’s Vaccines Taskforce. . If you look at the development, we signed 15,000 people in six weeks in a trial set up by the NHS. Speed is everything in clinical development.

Vaccination 141

Vaccination Vaccine Manufacturing Clinical Development 141

pharmaphorum

JULY 8, 2022

The pharmaceutical industry is increasingly relying on artificial intelligence to power its drug discovery and development efforts, and its spend in this area has created a multibillion-dollar market for AI technologies. The post Pharma’s spend on AI in drug discovery ‘could top $3bn by 2025’ appeared first on.

Drugs 130

Drugs Clinical Development Marketing Genome 130

pharmaphorum

JUNE 1, 2022

Astellas has become the latest big pharma company to sink some money into immuno-oncology start-up GO Therapeutics, forging an alliance to develop antibodies targeting two glycoprotein targets. The Japanese drugmaker is paying $20.5 The Japanese drugmaker is paying $20.5

Gene Therapy 98

Gene Therapy Clinical Development Antibody Gene 98

pharmaphorum

APRIL 12, 2022

Separating the amount of antibiotic used from the payment model could entice pharma companies – who have abandoned antimicrobial R&D in their drives in the last decades – to enter the category once again and help to develop new drugs that will tackle the pressing issue of antimicrobial resistance (AMR).

Pharma Companies 117

Pharma Companies Development Drugs Medicine 117

Outsourcing Pharma

MARCH 14, 2022

The pharma company and academic institution will explore the viability of a psychedelic treatment to help patients suffering from cancer-related distress.

Pharma Companies 122

Pharma Companies Clinical Development Development 122

Outsourcing Pharma

OCTOBER 24, 2023

Clinical stage pharma company PharmaKure believe their combined drug targeting amyloid deposits associated with Alzheimerâs Disease can bring quality of life to patients.

Pharma Companies 52

Pharma Companies Trials Drugs Clinical Development 52

Outsourcing Pharma

OCTOBER 24, 2023

Clinical stage pharma company PharmaKure believe their combined drug targeting amyloid deposits associated with Alzheimerâs Disease can bring quality of life to patients.

Pharma Companies 52

Pharma Companies Drugs Clinical Development Development 52

Outsourcing Pharma

OCTOBER 6, 2022

The Danish company becomes the latest large pharma company to invest in NLRP3 assets, with these types of treatments holding the potential to treat a variety of diseases linked to inflammation.

Pharma Companies 78

Pharma Companies Clinical Development Development 78

pharmaphorum

OCTOBER 15, 2021

Pharma companies are embracing patient centricity in drug development more than ever before. Over the last decade, leaders in the industry have championed patient engagement, putting it at the heart of commercial strategies. I don’t want to be called a patient, and I’m not on a journey.”. “I

Pharma Companies 40

Pharma Companies Clinical Development Medicine Development 40

Outsourcing Pharma

OCTOBER 6, 2022

is the first startup to emerge from the alliance of pharma companies and investors that created AION Labs, and will focus on improving the efficacy and safety of drug candidates.

Pharma Companies 72

Pharma Companies Drugs Clinical Development Development 72

Outsourcing Pharma

FEBRUARY 7, 2023

The pharma company provides funding to 24 community organizations throughout the US, as part of its newly created âToward Health Equity Oncology Grantâ.

Pharma Companies 52

Pharma Companies Clinical Development Development 52

pharmaphorum

DECEMBER 21, 2021

Novartis has joined the ranks of big pharma companies developing TIGIT-targeted drugs for cancer, and found its candidate in an existing partner, Chinese biotech BeiGene. Pharma companies are looking at whether blocking TIGIT as well as PD-1/PD-L1 can improve the efficacy of cancer immunotherapy.

Drugs 98

Drugs Antibody Pharma Companies Development 98

pharmaphorum

SEPTEMBER 3, 2020

King’s Cross is also home to Google’s DeepMind artificial intelligence company, which has already been involved in life sciences projects such as using the technology to predict acute kidney injury. She added: “Using technologies like AI is a critical part of helping us to discover and develop medicines for serious diseases.”.

Life Science 112

Life Science Engineer Scientist Pharma Companies 112

Outsourcing Pharma

NOVEMBER 15, 2021

The pharma company has completed enrollment of amyotrophic lateral sclerosis patients in its study investigating drugs like verdiperstat, an oral treatment.

Clinical Trials 69

Clinical Trials Clinical Trials Pharma Companies Trials 69

Drug Discovery World

OCTOBER 18, 2022

The second phase will see it develop a methodology for calculating the carbon footprint of both trial models. The CoI currently has 25 members from Japan, US, and Europe, including top 10 pharma companies, CROs, and academic representatives. Growing pressure on life sciences.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Life Science 52

BioPharma Reporter

NOVEMBER 3, 2022

Purdue University and the pharma company will create a scholarship program and renew their strategic research collaboration as part of the agreement.

Manufacturing 52

Manufacturing Pharma Companies Research Clinical Development 52

pharmaphorum

FEBRUARY 26, 2021

UCB and Microsoft have announced a multi-year strategic collaboration to advance the digitalisation of the Belgian pharma company and accelerate its research efforts. The companies have already been working together on the COVID Moonshot Project, which aimed to create an orally available antiviral to combat the SARS-CoV-2 coronavirus.

Drugs 95

Drugs Medicine Pharma Companies Clinical Development 95

pharmaphorum

DECEMBER 15, 2021

Going from the vital activity of patient engagement to the more encompassing state of patient centricity requires big steps in the evolution of new-drug discovery, development, and delivery. It is drug developers, patients, advocates, and caregivers in active conversations—more likely to involve clean sheets of paper than prepared scripts.

Pharma Companies 145

Pharma Companies Development Medicine Clinical Trials 145

pharmaphorum

DECEMBER 22, 2021

Gyroscope Therapeutics and its gene therapy for the sight-robbing disease geographic atrophy (GA) has been acquired by a big pharma company – but likely not the one you would expect. Last year, it also signed a licensing deal with Dyno Therapeutics for its AAV capsid-based gene delivery technology focused on ocular diseases.

Gene Therapy 104

Gene Therapy Gene Licensing Licensing 104

pharmaphorum

JULY 7, 2022

As this issue’s contributors discuss, by working together pharma companies and healthcare providers can significantly enhance oncology treatment for patients. Therapeutic cancer vaccine trials have an opportunity to leverage recent interest in vaccine technology to make headway in oncology, says Advanced Clinical’s Christopher Oelkrug.

Vaccination 52

Vaccination Vaccine Life Science Trials 52

pharmaphorum

MAY 4, 2022

In testing new treatments, what is promising in animal models may not transfer particularly well to humans, which helps to explain why there is a 90% failure rate during clinical development. Quris has taken its technology and used it to develop its own drug candidate pipeline.

Drugs 143

Drugs Licensing Licensing Pharma Companies 143

XTalks

OCTOBER 22, 2020

Pharmaceutical development of novel drugs is a complex and tedious process. To achieve transparency and actionability of data, pharmaceutical companies are evolving their manufacturing processes by digitalizing the data from all of their equipment. Nevertheless, they have succeeded to continue the process development to the next stage.

Manufacturing 98

Manufacturing Development Production Gene Therapy 98

pharmaphorum

JULY 6, 2022

A Franco-German joint venture company – Aurobac Therapeutics – has been formed to try to tackle the rising threat of antimicrobial resistant (AMR) infections. It’s the latest in a series of actions taken by the drug industry to try to reverse the mass exodus of companies from antimicrobials R&D over the last few decades.

In-Vitro 57

In-Vitro Development Pharma Companies Drugs 57

Drug Discovery World

DECEMBER 27, 2023

Developing. Ng is working on critical challenges in clinical trials, specifically in planning and recruitment, and has been building innovative solutions designed to benefit patients and researchers – with a focus on efficiency, transparency and diversity in clinical development. DDW Highlights Innovative. Listen here.

Clinical Trials 69

Clinical Trials Clinical Trials Drugs Development 69

Pharmaceutical Technology

JUNE 15, 2023

Developing a new drug is a monumental achievement — the reward of years of research and innovation. Successful innovation requires enormous effort from countless project teams that build on the medical, scientific and technological research and development of generations before them.

Pharma R&D 130

Pharma R&D Production Manufacturing Development 130

XTalks

MARCH 28, 2024

The FDA’s approval of Duvyzat for DMD, based on our robust and successful clinical development program, reflects Italfarmaco’s commitment to providing a safe and proven-effective therapy that can have a meaningful impact for people living with DMD,” said Paolo Bettica, MD, PhD, chief medical officer at Italfarmaco Group in a press release.

FDA Approval 105

FDA Approval Genetics Gene Therapy Gene 105

pharmaphorum

MAY 3, 2022

The new drug – Quviviq (daridorexant) – has been approved by the European Commission for adults who have been suffering insomnia for at least three months and are experiencing “considerable impact” on daytime functioning, according to the Swiss pharma company.

Marketing 97

Marketing Drugs Sales Pharma Companies 97

pharmaphorum

JULY 1, 2021

The German startup has developed a cuff electrode that allows selective stimulation of fibres in the vagus nerve, which carries an extensive range of signals from the body to the brain and vice versa.

Drug Delivery 94

Drug Delivery Pharma Companies Clinical Development Development 94

pharmaphorum

APRIL 22, 2021

Biosensor firm physIQ has licensed its technology to Johnson & Johnson’s Janssen pharma unit in a multi-year deal, to investigate use of wearable sensors in virtual clinical trials. The pharma company will use the technology known as accelerateIQ to collect data across its clinical studies through a variety of wearable biosensors.

Licensing 70

Licensing Licensing Trials Clinical Trials 70

The Pharma Data

JANUARY 4, 2021

Rothenberg did not provide any information as to what his next role may be – whether he will take over the helm of a pharma company or assume a role on one or more boards of directors. BioSpace reached out to Rothenberg for comment and will update following a response.

HR 52

HR Clinical Development Scientist Pharma Companies 52

Outsourcing Pharma

JULY 27, 2020

Elucid Digital Healthâs Pill Connect is designed to enable CROs and pharma companies to monitor patient adherence during a clinical trial.

Pharma Companies 52

Pharma Companies Clinical Trials Clinical Trials Drugs 52

pharmaphorum

JANUARY 24, 2022

Francisco Partners is picking up a range of databases and analytics tools – including Health Insights, MarketScan, Clinical Development, Social Programme Management, Micromedex and other imaging and radiology tools – for an undisclosed sum estimated to be in the region of $1 billion.

Radiology 109

Radiology Marketing Genome Genomics 109

pharmaphorum

APRIL 28, 2022

Although they have, by definition, small addressable markets, the treatments cost just as many resources to develop as therapies for more common diseases – sometimes more, because of the added difficulty of finding sufficiently large patient populations for trials and finding disease experts to run them. Alexion’s new development hub.

Pharma Companies 57

Pharma Companies Branding Development Marketing 57

pharmaphorum

SEPTEMBER 29, 2020

As of 2018, there were over 1,100 cancer therapies in development, and as of 2020, 362 of them were cell and gene therapies. As a result, there is a need for continued innovation and increased efficiency in terms of drug development to manage cost, complexity and speed to provide potentially transformative therapies for cancer patients.

Research 132

Research Gene Editing Gene Development 132

Delveinsight

AUGUST 2, 2020

The company has also signed a licensing agreement with Ono Pharmaceutical , a Japanese pharma company, transferring exclusive rights to develop and commercialise anamorelin in Japan, South Korea, and Taiwan. Cancer Cachexia Pipeline. Apart from the products as mentioned earlier, Tetra Bio?Pharma,

Marketing 94

Marketing Pharma Companies Development Hormones 94

pharmaphorum

NOVEMBER 11, 2022

” Most large pharma companies have also ramped up public commitments to close clinical trial diversity gaps, says the report, including operational measures like inclusive early trial planning, diversity metric tracking, selection of sites, and execution of study participant recruitment programmes.

Clinical Trials 97

Clinical Trials Clinical Trials Trials Pharma Companies 97